Patent details

Basic Information

Publication number:

EP3192500

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171583602

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR CONTINUOUS ADMINISTRATION OF DOPA DECARBOXYLASE INHIBITORS

French Title of Invention:

COMPOSITIONS POUR ADMINISTRATION CONTINUE D'INHIBITEURS DE LA DOPA DÉCARBOXYLASE

German Title of Invention:

ZUSAMMENSETZUNGEN FÜR DIE KONTINUIERLICHE VERABREICHUNG VON DOPA-DECARBOXYLASEHEMMERN

SPC Number:

Dates

Filing date:

17/05/2010

Grant date:

02/12/2020

EP Publication Date:

19/07/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/12/2020

EP B1 Publication Date:

02/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/05/2021

Expiration date:

17/05/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/11/2020

 

 

Name:

Neuroderm Ltd

Address:

3 Pekeris Street, Rehovot 7670212, Israel (IL)

Inventor

1

Name:

YACOBY-ZEEVI, Oron

Address:

Israel (IL)

2

Name:

NEMAS, Mara

Address:

Israel (IL)

Priority

Priority Number:

179511 P

Priority Date:

19/05/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/08; A61K 9/10; A61K 31/198; A61P 25/16;

Publication

European Patent Bulletin

Issue number:

202049

Publication date:

02/12/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages